These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26501117)

  • 41. Ebola research funding: a systematic analysis, 1997-2015.
    Fitchett JR; Lichtman A; Soyode DT; Low A; Villar de Onis J; Head MG; Atun R
    J Glob Health; 2016 Dec; 6(2):020703. PubMed ID: 27909582
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of research investment on scientific productivity of junior researchers.
    Farrokhyar F; Bianco D; Dao D; Ghert M; Andruszkiewicz N; Sussman J; Ginsberg JS
    Transl Behav Med; 2016 Dec; 6(4):659-668. PubMed ID: 27351991
    [TBL] [Abstract][Full Text] [Related]  

  • 43. How can we improve priority-setting for investments in health research? A case study of tuberculosis.
    Khan MS; Rahman-Shepherd A; Painter H; Fletcher H
    Health Res Policy Syst; 2019 Jul; 17(1):68. PubMed ID: 31324187
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Public funding and private investment for R&D: a survey in China's pharmaceutical industry.
    Qiu L; Chen ZY; Lu DY; Hu H; Wang YT
    Health Res Policy Syst; 2014 Jun; 12():27. PubMed ID: 24925505
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Research outputs in respiratory medicine.
    Rippon I; Lewison G; Partridge MR
    Thorax; 2005 Jan; 60(1):63-7. PubMed ID: 15618586
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mapping of available health research and development data: what's there, what's missing, and what role is there for a global observatory?
    Røttingen JA; Regmi S; Eide M; Young AJ; Viergever RF; Ardal C; Guzman J; Edwards D; Matlin SA; Terry RF
    Lancet; 2013 Oct; 382(9900):1286-307. PubMed ID: 23697824
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mapping the European cancer prevention research landscape: A case for more prevention research funding.
    Schmutz A; Matta M; Cairat M; Espina C; Schüz J; Kampman E; Ervik M; Vineis P; Kelm O
    Eur J Cancer; 2023 Dec; 195():113378. PubMed ID: 37924646
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Investment in pneumonia and pneumococcal research.
    Head MG; Fitchett JR; Newell ML; Scott JAG; Clarke SC; Atun R
    Lancet Infect Dis; 2014 Nov; 14(11):1037-1038. PubMed ID: 25444398
    [No Abstract]   [Full Text] [Related]  

  • 49. Research funding for addressing tobacco-related disease: an analysis of UK investment between 2008 and 2012.
    Hall M; Bogdanovica I; Britton J
    BMJ Open; 2016 Jul; 6(7):e011609. PubMed ID: 27377637
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Investing in health R&D: where we are, what limits us, and how to make progress in Africa.
    Simpkin V; Namubiru-Mwaura E; Clarke L; Mossialos E
    BMJ Glob Health; 2019; 4(2):e001047. PubMed ID: 30899571
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tracking Australian health and medical research expenditure with a PubMed bibliometric method.
    Mendis K; Bailey J; McLean R
    Aust N Z J Public Health; 2015 Jun; 39(3):227-31. PubMed ID: 25904290
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A landscape review of the published research output relating to respiratory syncytial virus (RSV) in North & Central America and Europe between 2011-2015.
    Kirolos A; Christides A; Xian S; Reeves R; Nair H; Campbell H
    J Glob Health; 2019 Jun; 9(1):010425. PubMed ID: 31131100
    [TBL] [Abstract][Full Text] [Related]  

  • 53. European diabetes research and its funding, 2002-2013.
    Begum M; Lewison G; Sommariva S; Ciani O; Tarricone R; Sullivan R
    Diabet Med; 2017 Oct; 34(10):1354-1360. PubMed ID: 28636762
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Less research on tuberculosis than HIV and malaria when research agendas are poorly coordinated: a systematic review of research outputs from Cambodia.
    Khan M; James R; Sundaram N; Wu S; Eang MT; Vonthanak S; Coker R
    Int J Infect Dis; 2017 Mar; 56():25-29. PubMed ID: 27979784
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Community-acquired pneumonia in the United Kingdom: a call to action.
    Chalmers J; Campling J; Ellsbury G; Hawkey PM; Madhava H; Slack M
    Pneumonia (Nathan); 2017; 9():15. PubMed ID: 29043150
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Global Fund to Fight AIDS, Tuberculosis and Malaria's investments in harm reduction through the rounds-based funding model (2002-2014).
    Bridge J; Hunter BM; Albers E; Cook C; Guarinieri M; Lazarus JV; MacAllister J; McLean S; Wolfe D
    Int J Drug Policy; 2016 Jan; 27():132-7. PubMed ID: 26342275
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of Global Pediatric Cancer Research and Publications.
    Syrimi E; Lewison G; Sullivan R; Kearns P
    JCO Glob Oncol; 2020 Feb; 6():9-18. PubMed ID: 32031437
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The activity of the Research Investments in Global Health study and ways forward within the global funding and policy landscape.
    Head MG; Brown RJ
    BMC Proc; 2016; 10(Suppl 8):59. PubMed ID: 28813540
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Macular disease research in the United Kingdom 2011-2014: a bibliometric analysis of outputs, performance and coverage.
    Royle P; Waugh N
    BMC Res Notes; 2015 Dec; 8():833. PubMed ID: 26715430
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Global health equity in United Kingdom university research: a landscape of current policies and practices.
    Gotham D; Meldrum J; Nageshwaran V; Counts C; Kumari N; Martin M; Beattie B; Post N
    Health Res Policy Syst; 2016 Oct; 14(1):76. PubMed ID: 27724907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.